In this episode of Weekly Dose, we cover a wide range of important clinical findings. We discuss the feasibility of digital cognitive assessments for Alzheimer disease screening in primary care, patient preferences for atopic dermatitis treatments, and the impact of social determinants of health on hormonal therapy use among midlife women. Additionally, we explore the FDA's Breakthrough Device designation for a multi-cancer detection test and new findings linking the quality of low-carb and low-fat diets to coronary heart disease prevention. Tune in for these key insights that are shaping clinical practice.